The U.S. Food and Drug Administration (FDA) just recently revoked the emergency use authorization (EUA) for bamlanivimab, the investigational monoclonal therapy, when administered alone for…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.